$12.13
+0.01 (+0.08%)
Open$12.17
Previous Close$12.12
Day High$12.42
Day Low$11.79
52W High$18.69
52W Low$6.92
Volume—
Avg Volume509.7K
Market Cap803.02M
P/E Ratio—
EPS$-1.88
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
+104.2% upside
Current
$12.13
$12.13
Target
$24.77
$24.77
$14.60
$24.77 avg
$27.54
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 120.94M | 163.92M | 205.11M |
| Net Income | -254,610,908 | -310,585,276 | -12,900,416 |
| Profit Margin | -210.5% | -200.0% | -6.3% |
| EBITDA | -204,329,436 | -263,096,996 | -15,864,221 |
| Free Cash Flow | — | — | -6,278,593 |
| Rev Growth | -26.2% | -26.2% | +24.6% |
| Debt/Equity | 0.24 | 0.24 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |